Background: Coumarin and thiazole derivatives have been used traditionally for many centuries. Because they have anti-tumor, antioxidant activities, and induced apoptosis. Aim: The present study aims to investigate the in vivo antitumor, and antioxidant activities of potassium salt of 5-(4 -chlorophenyl)-2-[(7-hydroxy coumarin-3-ylethylidene) acetyl hydrazine]-1,3 thiazole (5a) and 5-(4 -chlorophenyl)-2-[(8-hydroxy coumarin-3-ylethylidene) acetyl hydrazine]-1,3 thiazole (5b). Materials and Methods: Toxicity has been determined for the synthesized compound. Anti-cancer and anti-oxidant activities were studied through the evaluation of tumor cell viability, lifespan prolongation and antioxidant estimation. Results: Doses of up to 500 mg/kg showed good protection in 5a and 5b compounds. Results of in vivo anti-tumor activity against Ehrlich ascites carcinoma (EAC) cells for the compounds studied showed a significant reduction in the volume and number of ascites. And increased in life span. In therapeutic and preventive groups, compounds 5a and 5b have anti-oxidant properties by a Mohammed et al.; AJRB, 5(4): 1-15, 2019; Article no.AJRB.53368 2 significant decrease in malondialdehyde and significant increased catalase and GSH. Also, compounds 5a and 5b induced apoptosis by increase Caspase-3 and BCL-2 associated protein (BAX), Compared to the group of positive controls. Conclusion: It was concluded that compounds 5a and 5b have a potent antitumor and antioxidant activity against Ehrlich ascites carcinoma in mice.
INTRODUCTION
Cancer is a wide range of diseases that are associated with abnormal growth of cells. According to the World Health Organization, approximately one-third of deaths from cancer are related to poor nutrition and daily habits such as high-fat diets, lack of exercise, low fiber intake, tobacco, and alcohol consumption. On the other hand, one-fifth of cancer deaths are associated with viral infections such as hepatitis B and C viruses and human papillomavirus in economically less developed countries [1] .
In 2012, GLOBOCAN reported around the world 14.1 million new cases and 8.2 million cancerrelated deaths [2] . The design and development of new particles for cancer treatment have spurred tremendous interest in many industrial and academic research laboratories around the world. The biological activities of different compounds, either artificial or natural, have been investigated extensively around the world. The applications of these compounds in medical research have increased widely to develop the treatment methods of various diseases. Unfortunately, several of these compounds are not suitable for therapeutic use because of their toxicity level, carcinogenic effect, and mutagenic property. As technology and knowledge advance, it is possible to synthesize an active compound of the molecular structure with improved therapeutic activity and reduced toxicity [3, 4] . Coumarins are bioactive compounds of both nature and synthetic origin, and due to their useful and diverse pharmaceutical and biological activities, there has been a growing interest in their synthesis [5] .
Coumarin compounds possessing anti-bacterial [6, 7] , Antifungal [8] [9] [10] , anticoagulant [11] , antituberculosis [12] , anti-inflammatory [11] , antitumor [13, 14] , anti-human immunodeficiency virus (HIV) activities [15] . Its substitution effectively influences the biological activities of the synthesized coumarin derivatives. These substitutions in the coumarin nucleus are very important in the design and development of new coumarin derivatives with remarkable biological properties for the prediction of structure-activity relationship (SAR) analysis. Thiazole, you know. Compounds play an important role in nature and have a number of biological effects, including antitumors. [16] [17] [18] , antibacterial [19] , antimicrobial [20] , anti-viability [21] , antiinflammatory [22] , Syk inhibitor [23] , antiviral [24] , antiproliferative [25] and anticandidal activity [26] .
MATERIALS AND METHODS

Materials
Chemicals
2,4-dihydroxybenzaldehyde, 2,3 dihydroxybenzaldehyde, ethyl acetoacetate, piperidine, thiosemicarbazide, ethanol, acetic acid, p-chlorophenacyl bromide, sodium acetate, potassium hydroxide were obtained from El-Gomhoria Chemical Co. Port-said. All chemicals were used as received without extra purification.
Animals
Female Swiss albino mice aged 8 weeks, weighing 22 to 25 g of body weights, were raised at the Faculty of Science, Port-said University's experimental animal house. The animals were kept in temperature, humidity, and lightcontrolled environments. They were fed on a standard commercial diet and adlibitum tap water.
Tumors
Ehrlich ascites carcinoma (EAC) was initially delivered by the National Cancer Institute in Cairo, Egypt, and maintained ascites at 8 or 10day intervals in our laboratory in female Swiss albino mice through serial intraperitoneal (I.P) inoculation.
Methods
Chemistry
The 7-hydroxy and 8-hydroxy-3-acetylcoumarins (2a, b) were prepared using 2,4-dihydroxybenzaldehyde cyclo condensation and 2,3-dihydroxybenzaldehyde in the presence of piperidine as a catalyst using the literature method [1, 2 ] . As a key starting material. Treatment of 3-acetylcoumarin derivatives (2a,b) with thiosemicarbazide in ethanol in the presence of acetic acid as catalyst under reflux led to the formation of 1-[(7-hydroxy and 8hydroxycoumarin-3-ylethylidene) amino]thioureas (3a,b).
5-(4-chlorophenyl)-2-[(7-hydroxy
and/or 8hydroxy coumarin-3-ylethylidene) acetyl hydrazino]-1,3-thiazoles (4a,b) were prepared via the cyclization of thiourea derivatives (3a,b) with 4-chlorophenacyl bromide in acetic acid in the presence of fused sodium acetate under reflux.
Preparation of the compounds 2-5 was accomplished by means of a common synthetic procedure shown in Scheme 1.
The potassium salt of compounds (5a,b) was formed via the dissolving thiazole derivatives (4a,b) in equal two equivalent moles of potassium hydroxide solution (equal volumes from water and ethanol) and the removal of the solvent at room temperature.
Determination of median lethal dose (LD 50) of the synthesized compounds
Approximate LD50 of newly synthesized compounds in mice has been determined using the Meier and Theakston methods [27] .
Scheme 1. Synthesis of 1,3 thiazole derivatives (4 and 5)
Experimental design
60 Swiss albino mice were divided into 6 groups of 10 mice each: group I "acted as a negative control group" injected with sterile saline for 10 days (day after day); group 2 "positive control;" intraperitoneal (i.p.) injected with 2.5x106 of Ehrlich ascites carcinoma "EAC" cells. Group 3"5a therapeutic group, injected intraperitoneal (I.P.) with 2.5 mg/kg one day after EAC injection and repeated doses five times during the experiment; Group 4" 5a Preventive Group: injected I.P. with compound 5a (2.5 mg/Kg) before injection with EAC cells (2.5×106 cells/mouse) and repeated dose five times during the experiment. Group 5 "5b therapeutic group", injected i.p. with 5 mg/kg one day after EAC injection and repeated dose five times during the experiment. Group 6 " injected I.P. with compound 5b (5 mg/Kg) before injection with EAC cells (2.5×106 cells/mouse) and repeated dose five times during the experiment. At the end of the experiment, EAC cells were harvest from each mouse in a centrifuge tube containing heparinized saline. Note the volume of ascetic fluid in each mouse in each group. Each sample of cells was undergoing viability tests of EAC cells, and antioxidants assays were performed Zahran, F et al. [28] .
Life span prolongation
Life span calculation was done using the method described by Mazumdar et al. [29] .
Evaluation of Tumor volume
The volume of the EAC was detected by measuring tube in milliliters (ml) [30] .
Determination of cell viability
100 μl of Ehrlich ascites cells were stained with trypan blue for 15 minutes, and the number of viable cells was counted using homocytometers as follows;
Number of cells / ml = average × 25 ×104× dilution factor
Evaluation of antioxidant parameters
Malondialdehyde level (MDA), catalase level (CAT), and reduced glutathione level (GSH) are calculated by Satoh [31] ; Aebi [32] methods.
Evaluation of apoptosis assays
The caspase-3 activity was calculated by the caspase-3 colorimetric kit according to the method of Casciola [33] .
Statistical Analysis
Statistical analysis was conducted using version 14 of SPSS Software II [34] . Data were expressed as mean ± SE. Student (t) test and One-way ANOVA test were performed to detect the significance variation between test groups and control.
RESULTS
Determination of Median Lethal Dose LD50 of Synthetic Compounds
The acute toxicity was estimated by intraperitoneal administration of compounds to determine the median lethal dose (LD50) of compounds 5a and 5b. Our results showed that in compounds 5a and 5b, doses up to 500 mg/kg are considered safe, where no mortality was observed. Table 1 summarized the effect of compounds 5a and 5b on EAC cell volume and count. The mean count of EAC cells in the positive control group was found to be 233 ×106 cells, which significantly decreased to 165, 137, 144, 171(106) by 29.2% and 41.6%; by 38.2 % and 26.6% (P <0. 01), respectively in therapeutic and preventive groups of compounds 5a and 5b; respectively.
The Effect of Test Compounds 5a and 5b on Tumor Volume, Viability of EAC Cells
Also, the mean volume of EAC in the positive control group was found to be 3.65 (mL). While This volume was significantly decreased in compounds 5a and 5b to 1.92, 1.4, 2.25, 1.25 mL by 47.4%, and 61.6%; by 38.4%, and by 65.8%, (P <0. 01); respectively in therapeutic and preventive groups compared to the positive control group. Table 2 illustrated the life span prolongation of the studied tested compounds.
Effect of Tested Compounds on Life Span in All Studied Groups
The mean life span prolongation in the positive control group was found to be 14 days compounds 5a and 5b therapeutic and preventive groups showed a significantly increased in the life span prolongation to 20 days by 42.9% (T/c ratio = 142.9%), 19 days by 35 .7% (T/c ratio = 135.7%), 15 days by 7.14% (T/c ratio = 107.1%), 23 days by 64.3% (T/c ratio = 164.3%), respectively; compared to the positive control group. respectively; compared to the positive control group; as showed in Fig. 5 . Table 6 illustrated the EAC apoptosis assays of the investigated compounds.
Antioxidants Assays
The Effect of compounds 5a and 5b on oxidant and Antioxidants in EAC of all studied groups
The Effect of compound 5a and 5b on oxidant and Antioxidants in the liver of all studied groups
Apoptosis Assays
Effect of tested compounds on caspase-3 and Bax (BCL-2 associated protein) in EAC of all studied groups
The mean values of EAC Caspase 3 activity in positive control were found to be 0.270±0.004 (ng/mL). Treatments by Compounds 5a and5b showed highly significant increase to 0.398±0.042 and 0.76±0.1371(ng/mL); 1.18±0.0725 and 0.7±0.044 (ng/mL) by 47.4%, 181.5%; 337%, 159.25% in both therapeutic and preventive groups, respectively. Compared to the positive control group (p<0.01), as shown in Fig. 7 .
It also showed very highly significant increase in EAC BAX to be 3.44±0.126 and 3.98±0.24 (ng/mL); 6.34±0.78 and 3.85 ±0.23 (ng/mL) by 60.74% and 86.3%; 196.3% and 80.3% in both therapeutic and preventive groups, respectively. Compared to the positive control group 2.14±0.125 (ng/mL). (p<0.001) showed in Fig. 9 .
Fig. 4. liver Catalase in all studied groups
*There is a very highly significant increase in liver catalase in compounds 5a&5b therapeutic and preventive groups Fig. 5 . EAC Glutathione reduced in all studied groups *There is a very highly significant increase in EAC Glutathione reduced levels in compounds 5a&5b therapeutic and preventive groups ***P value <0.001 was considered very highly significant, *There is a very highly significant reduction in EAC MDA levels in compounds 5a&5b therapeutic and preventive groups, **There is a very highly significant increase in both EAC catalase and G.reduced activity in compounds 5a &5b therapeutic and preventive groups ***P value <0.001 was considered very highly significant, *There is a very highly significant reduction in liver MDA levels in compounds 5a&5b therapeutic and preventive groups, **There is a very highly significant increase in both liver catalase and G.reduced activity in compounds 5a &5b therapeutic and preventive groups 9 P value <0.001 was considered very highly significant, **There is a very highly significant increase in EAC caspase-3 and Bax levels in compounds 5a&5b therapeutic and preventive groups P value <0.001 was considered very highly significant, **There is a very highly significant increase in liver caspase-3 and Bax levels in compounds 5a&5b therapeutic and preventive groups Table 7 illustrated the liver apoptosis assays of the investigated compounds.
Effect of tested compounds on caspase-3 and Bax (BCL-2 associated protein) in the liver of all studied groups
The mean values of Caspase-3 in the liver tissue were found to be 3.07 ± 0.119 (ng/ml) in negative control group .These values were decreased in the positive control group to 0.905± 0.245 (ng/mL) by 70.57%, (p<0.01). While, the mean values of Caspase-3 activities for both therapeutic and preventive groups treatments with Compound (5a, 5b) showed highly significant increase to be 1.93±0.13, 2.98± 0.04 (ng/ml); 2.41±0.038 and 2.17±0.18 (ng/ml) by 113.25% and 229.4%; 116.9% and 139.77% (p<0.01), respectively; compared to the positive control group (p<0.01) showed in Fig. 8 .
Also, the mean values of BAX levels in the liver tissue were found to be 17.84±0.204 (ng/ml) in the negative control group. These values were very highly significant, decreased to 9.92± 0.35(ng/mL) in the positive control group by (p<0.001). the mean values of BAX levels were very highly significant increased for both therapeutic and preventive groups treatments with Compound (5a, 5b) to be 10.16±0.33 and 12.2± 0.59(ng/ml); 9.93 ±0.08 and 10.29±0.23 (ng/ml) by 2.42%, 22.98%, 0.1% and 3.72% (p<0.01), respectively; compared to the positive control group showed in Fig. 10 .
Fig. 6. Liver Glutathione reduced in all studied groups
*There is a very highly significant increase in liver Glutathione reduced levels in compounds 5a&5b therapeutic and preventive groups Fig. 7 . EAC Caspase-3 in all studied groups *There is a very highly significant increase in EAC caspase-3 in compounds 5a and 5b therapeutic and preventive groups Fig. 8 . Liver Caspase-3 in all studied groups *There is a very highly significant increase in liver caspase-3 in compounds 5a and 5b therapeutic and preventive groups Fig. 9 . EAC BAX level in all studied groups *There is a very highly significant increase in EAC Bax in compounds 5a and 5b therapeutic and preventive groups Fig. 10 . Liver BAX level in all studied groups *There is a very highly significant increase in liver Bax levels in compound 5a and 5b therapeutic and preventive groups
DISCUSSION
Cancer is a disease caused by dysregulated cellular signaling process in cell homeostasis and proliferation and caused by a combination of genetic mutation and internal or external oncogenic stimuli [35] . Chemotherapy in cancer therapy [36] is proven to be an effective and safe treatment option that uses multiple drugs and hormonal agents alone or in combination [37] . The synthetic drugs used for chemotherapy, in addition to being toxic to cancer cells, also have a lethal effect on normal cells due to their non-specificity, which only works on cell division [38] .
This paper describes the evaluation of the antitumor, anti-oxidant effects of synthetic potassium salt of 5-(4 -chlorophenyl)-2-[(7-hydroxy coumarin-3-ylethylidene) acetyl hydrazine]-1,3 thiazole (5a) and potassium salt of 5-(4chlorophenyl)-2-[(8-hydroxy coumarin-3ylethylidene) acetyl hydrazine]-1,3 thiazole (5b) . Our results found that these doses were significantly prolonged the life span to 20 days by 42.9%, 19 days by 35.7%, 15 days by 7.14%, 23 days by 64.3%, in therapeutic and preventive groups; respectively compared to the positive control group as shown in Table 1 .
A rapid increase in the volume of ascetic tumors was observed in EAC tumor-bearing mice, and treatment with compounds 5a and 5b increased the life span of EAC-bearing mice by reducing the viability of EAC cells and decreasing the tumor volume due to present of coumarin and thiazole ring in compounds 5a and 5b, which have been shown to possess anticancer properties. Such results are consistent with the observation of Gabr et al. [39] . The thiazolylcoumarin derivatives have the highest in vitro antitumor activity in mice against EAC cells. Increasing the life span of EAC inoculated mice (%ILS), decreasing the number of viable tumor cells.
Our results found that compounds 5a & 5b treatment also decreased the levels of MDA (malondialdehyde) and raised the values of GSH (reduced glutathione), Catalase. These results prove the cytotoxic efficacy of compounds 5a & 5b on tumor cells. Also, in this research, a decrease in CAT and GSH and an increase in MDA levels were noticed in EAC bearing mice. Compound 5a & 5b treatment prevents the reduction in antioxidant levels and rises in MDA levels in EAC bearing mice, which prove the potency of these compounds in protecting against oxidative stress by normalization of antioxidants values in EAC bearing mice. Lowering in antioxidants and raising in MDA is assign to cancer. Flow cytometric analysis shows that the arrest of a cell cycle mostly occurs in the S phase then leads to apoptosis because the aneuploid ratio is permanently and strongly relate to the S phase, which produces proliferation. This may indicate that compounds 5a & 5b interfere with DNA replication. Apoptosis is a programmed cell death process in which biochemical events lead to cell changes and death that are characteristic. As a biological phenomenon and defective apoptotic processes involved in many diseases, apoptosis is essential.
Excessive apoptosis triggers atrophy, whereas inadequate apoptosis contributes to the uncontrolled proliferation of cells, which leads to cancer. Some factors, such as fas receptors and caspases, promote apoptosis, while individual members of the protein family Bcl-2 inhibit apoptosis. Caspase-3 is also required for some typical hallmarks of apoptosis [40] . The two major pro-apoptotic Bcl-2 proteins, Bax and Bak, induce apoptosis through the development of mitochondrial outer membrane permeabilization (MOMP) complex [41] . MOMP formation results in the release from the mitochondrial intermembrane space of cytochrome c and other factors, which in turn activates the critical caspase cascade. The interactions between the Bcl-2 protein family's anti-apoptotic and pro-apoptotic proteins either inhibit or activate MOMP and determine the cell's fate [42] .
The present study showed treatment with compounds 5a and 5b cause an increase in liver and EAC caspase-3 activity and increase Bax level compared with positive control group. Therefore, the results of the present study suggested that treatment with compounds 5a and 5b may have induced apoptosis. Apoptosis induction is considered to be an active cancer therapy strategy [43] .
CONCLUSION
It was concluded that compounds 5a and 5b have a potent antitumor and antioxidant activity against Ehrlich ascites carcinoma in mice. The compound 5b is more active than compound 5a.
